410P Frequency and spectrum of primary resistance mechanism in Chinese ALK+ non-small cell lung cancer patients progressing on crizotinib: A multicenter study
2017 ◽
Vol 23
(24)
◽
pp. 7550-7557
◽
Keyword(s):
Keyword(s):
2017 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):